Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  SHENZHEN STOCK EXCHANGE  >  Beijing SL Pharmaceutical Co Ltd    002038   CNE000001L31

No quotes available
-- CNY   --.--%
04/28 BEIJING SL PHAR : 2014 Net Up 20%
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Beijing SL Pharmaceutical
Produces and supplies pharmaceutical products

Beijing SL Pharmaceutical Co. Ltd. engages in the development and marketing gene engineering drugs.

Its products include Li Sheng Su, a recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) injection; Mai Ge Er, a recombinant human Interleukin-11 (rhIL-11) injection; and Xin Ji Er, a recombinant human Ala Interleukin-2 (Ala IL-2) injection.

The company was founded by Ming Bo Xu in December 1994 and is headquartered in Beijing, China.

Number of employees : 629 persons.
Sales per Businesses
20132014Delta
CNY (in Million)%CNY (in Million)%
Bio-Pharmaceutical981.0284.5%1,01381.5% +3.14%
Biochemical131.5311.3%158.4212.7% +16.97%
Other Business35.003%36.002.9% +2.79%
Other14.231.2%35.752.9% +60.21%
Sales per Regions
20132014Delta
CNY (in Million)%CNY (in Million)%
China1,161100%1,243100% +6.57%
Managers
NameAgeSinceTitle
Mingbo Xu, PhD51-Chairman & President
Anjing Lu58-Chairman-Supervisory Board
Wenying Xi52-Chief Financial Officer
Yu Lin Chen70-Director
Xiu Jiang Wen38-Director-Supervisory Board
Qing Jun Ma79-Independent Director
Su Yan Wei63-Independent Director
Ming Xi Zhang, CPA452007Independent Director
Shujie Liang49-Board Secretary
Yong Bo Wang40-Vice President
Shareholders
NameShares%
Xinxiang State Owned Asset Sup. & Adm. Commssion 144,412,994 25.5%
Mingbo Xu, PhD 38,615,252 6.81%
China Resources SZITIC Trust Co., Ltd. 25,200,144 4.44%
Bin Wang 8,787,900 1.55%
Pacific Asset Management Co., Ltd. 4,449,335 0.78%
China Asset Management Co., Ltd. 4,338,539 0.77%
Norges Bank Investment Management 3,945,485 0.70%
Norges Bank Investment Management (China) 3,945,486 0.70%
Shanghai Broadvision Investment Management Co. Ltd. 3,437,429 0.61%
Yi Chao Wang 3,106,070 0.55%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
SHANGHAI RAAS BLO..
-
ACTELION LTD
MEDIVATION INC
GENMAB A/S
ZHONGYUAN UNION C..
-
BLUEBIRD BIO INC
INTERCEPT PHARMAC..
ULTRAGENYX PHARMA..
-
NEUROCRINE BIOSCI..
TONGHUA DONGBAO P..
JUNO THERAPEUTICS..
HUALAN BIOLOGICAL..
DYAX CORP.
AGIOS PHARMACEUTI..
CLOVIS ONCOLOGY I..
BEIJING SL PHARMA..
RADIUS HEALTH INC
-
CHINA BIOLOGIC PR..
3SBIO INC
-
INSYS THERAPEUTIC..
Sector Biotechnology & Medical Research
Beijing SL Pharmaceutical : Connections
Beijing Society of Biotechnology
Xinxiang Bailu Chemical Fiber Group Co. Ltd.
Chinese Society of Biotechnology
Beijing Institute of Technology
Beijing Jurassic Software Co., Ltd.
Accounting Society of China
Company contact information
Beijing SL Pharmaceutical Co., Ltd.
9 Zhongyuan Road
Bada High Development District
Beijing 100041

Phone : +86.10.8879.9370
Fax : +86.10.8879.5883
Web : www.slpharm.com.cn
© 2015 People , Fundamentals and Ownership